Eustachian tube dysfunction often determines whether a routine ear infection clears quickly or develops into a persistent ...
MedPage Today on MSN
For Your Patients: What to Know About the Newest Treatments for HR+/HER2- Breast Cancer
The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors combined with endocrine therapy (ET). This dual-therapy targets a pathway ...
Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...
Zacks Investment Research on MSNOpinion
3 communication stocks set to benefit from industry strength
The Zacks Communication - Infrastructure industry is poised to benefit from an increasing user propensity to stay abreast of ...
More money and industry innovation could help the Navy mitigate its challenges. But they don’t tackle the root cause of a ...
During early development, tissues and organs begin to bloom through the shifting, splitting, and growing of many thousands of ...
Cogent Biosciences (COGT) shares have surged after pivotal bezuclastinib data in imatinib-resistant aGIST. Read the latest ...
News-Medical.Net on MSN
MEA-driven graph modeling identifies early connectivity changes linked to autism
Multi-electrode arrays (MEAs) provide a noninvasive interface with sub-millisecond temporal resolution and long-term, ...
12don MSN
PFAS mixture disrupts normal placental development, which is important for a healthy pregnancy
Per- and polyfluoroalkyl substances (PFAS) are a group of nearly 10,000 long-lasting chemical compounds that stay in the ...
Roche RHHBY announced positive new data from a pre-specified interim analysis of its late-stage breast cancer study on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results